Clinical Trials Arena on MSN1d
Orca Bio makes a splash as T-cell therapy cuts GvHD in blood cancer patients
Graft versus host disease (GvHD) is a complication from stem cell transplants where the patient recognises the cells as ...
CURE1d
Orca-T Doubles Graft-Versus-Host Disease-Free Survival in Leukemia
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
PharmaTimes20h
Orca Bio’s T-cell therapy shows promise in haematological malignancies
Orca Bio has shared promising results from a late-stage study of its investigational allogeneic T-cell immunotherapy in ...
Removing a protein 'signal jammer' improves tumor response to immunotherapy
Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, ...
Fierce Biotech2d
Orca's cell therapy trounces traditional care in blood cancer phase 3, swimming into space's 'holy grail'
In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...
News-Medical.Net on MSN1d
In the Thymus We Trust: ProTcell Therapy & the Future of Allogeneic Immunotherapy
In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.
ZME Science on MSN2d
Scientists uncover how aspirin may help stop cancer from spreading
Essentially, aspirin can boost the immune system’s ability to fight cancer metastasis by stopping platelets — tiny blood ...
News Medical on MSN6h
Targeted inhibition of a 'signal jammer' protein may improve tumor response to immunotherapy
Targeted inhibition of a "signal jammer" protein may improve how tumors respond to immunotherapy. Published today in Nature, a new study demonstrates how some cancer cells use the protein ...
What Vanderbilt-Ingram Cancer Center's 'sci-fi' therapy means for this grateful TN dad
This cancer-patient dad of three young kids is grateful for a "sci-fi" blood treatment advanced by Vanderbilt and oncologist ...
Targeted Oncology2d
Orca-T Improves cGVHD-Free Survival Across Hematologic Malignancies
Orca-T improved 1-year survival without severe graft-vs-host disease compared with standard transplant in the Precision-T ...
Medical Dialogues1h
PGI to Set Up GMP Laboratory for Advanced Stem Cell, Gene Therapies
Chandigarh: The Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh is working towards establishing ...